Literature DB >> 28578713

Delayed-onset haematoma formation after cochlear implantation.

W-K Low1, S Xu1.   

Abstract

OBJECTIVE: This paper presents our experience on delayed-onset haematoma formation after cochlear implantation, a topic which has not been well discussed in the literature.
METHOD: Retrospective case review study.
RESULTS: Five children who had undergone cochlear implant surgery at 1.5 to 4 years of age (median, 2.5 years) were studied. The haematoma episodes occurred 2-12 years (median, 6 years) after cochlear implantation. Two patients had recurrent episodes. Two of the seven haematoma episodes were managed by needle aspiration alone, four by incision and drainage alone, and one by both needle aspiration and incision and drainage. Other than one patient with coagulopathy, there were no obvious predisposing factors, including trauma.
CONCLUSION: The majority of delayed-onset haematomas occurred without obvious predisposing factors. Needle aspiration can differentiate a haematoma from an abscess or cerebrospinal fluid leakage, and it provides an effective immediate therapeutic solution. However, aseptic techniques are emphasised to minimise the chances of an uncomplicated haematoma converting into a septic one.

Entities:  

Keywords:  Cochlear Implant; Complication; Hematoma

Mesh:

Year:  2017        PMID: 28578713     DOI: 10.1017/S0022215117001165

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Delayed-onset swelling around the implant after cochlear implantation: a series of 26 patients.

Authors:  Fan Shu; Minyun Yao; Yimeng Liu; Jieqing Cai; Muqing Xu; Shanshan Jiang; Xinyuan Tan; Jie Tang; Hongzheng Zhang
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-07-23       Impact factor: 3.236

2.  Management of delayed-onset skin flap complications after pediatric cochlear implantation.

Authors:  Qingling Bi; Zhongyan Chen; Yong Lv; Jie Luo; Naya Wang; Yuan Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-11       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.